Efficacy and safety of axitinib for metastatic renal cell carcinoma in patients on hemodialysis for end‐stage renal disease: Case series of eight patients-Reference-Cited by-同舟云学术

Efficacy and safety of axitinib for metastatic renal cell carcinoma in patients on hemodialysis for end‐stage renal disease: Case series of eight patients

Published:2019-08-25 Issue:11 Volume:26 Page:1081-1082
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Ishihara Hiroki¹^ORCID,Takagi Toshio¹,Kondo Tsunenori²,Yoshida Kazuhiko¹,Okumi Masayoshi¹,Tanabe Kazunari¹

Affiliation:

1. Department of Urology Tokyo Women's Medical University TokyoJapan

2. Department of Urology Tokyo Women's Medical University Medical Center East Tokyo Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14093

Reference8 articles.

1. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

2. Screening, Diagnosis, and Treatment of Cancer in Long-Term Dialysis Patients

3. Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre

4. One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patients

5. Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first‐line sunitinib: a medical chart review across ten centers in five European countries

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of Tyrosine Kinase Inhibitors;Clinical Journal of the American Society of Nephrology;2023-12-11

2. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment;Urologic Oncology: Seminars and Original Investigations;2023-11

3. Approach to Special Populations with Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

4. Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report;Case Reports in Oncology;2021-10-22

5. Renal Cell Cancer and Chronic Kidney Disease;Advances in Chronic Kidney Disease;2021-09